Abstract
AIM--To evaluate the performance of three newly introduced enzyme immunoassays (EIAs) for hepatitis C virus (HCV) antibodies, based on synthetic oligopeptides as antigens. METHODS--Referred serum samples (n = 173) from people representing groups at high risk of HCV infection were studied. An EIA based on second generation recombinant polypeptide antigens was used for comparison. EIA reactivities were validated by testing repeatedly reactive samples in two recombinant antigen based immunoblot assays. RESULTS--In samples from patients with liver dysfunction and those with bleeding disorders sensitivity of the three peptide based EIAs, manufactured by Innogenetics NV, Biokit SA, and United Biomedical Inc., were all 93%; specificity and efficiency were all greater than 95%. In samples from blood donors (previously tested as positive by the Ortho and Abbott Second Generation EIA) specificity, sensitivity, and efficiency were 95% or greater in all three peptide assays. Sensitivity, specificity, and efficiency of the recombinant antigen based Ortho Second Generation EIA were 100%, 89%, and 93%, respectively, in sera of patients with liver disease and those with bleeding disorders; and 100%, 43%, and 83%, respectively, in prescreened samples from blood donors. CONCLUSION--The peptide EIAs are more specific but less sensitive than the Ortho EIA. Peptide based EIAs should be useful in validating the specificity of Ortho EIA reactivities.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Farci P., London W. T., Wong D. C., Dawson G. J., Vallari D. S., Engle R., Purcell R. H. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis. 1992 Jun;165(6):1006–1011. doi: 10.1093/infdis/165.6.1006. [DOI] [PubMed] [Google Scholar]
- Hart G. Screening to control infectious diseases: evaluation of control programs for gonorrhea and syphilis. Rev Infect Dis. 1980 Sep-Oct;2(5):701–712. doi: 10.1093/clinids/2.5.701. [DOI] [PubMed] [Google Scholar]
- Hosein B., Fang C. T., Popovsky M. A., Ye J., Zhang M., Wang C. Y. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3647–3651. doi: 10.1073/pnas.88.9.3647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Inaba S., Fukuda M., Okochi K., Irita Y., Tokunaga K., Kiyokawa H., Maeda Y. HCV transmission after receiving anti-c100-negative blood units. Lancet. 1991 Jun 1;337(8753):1354–1354. doi: 10.1016/0140-6736(91)93036-9. [DOI] [PubMed] [Google Scholar]
- Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
- Lelie P. N., Cuypers H. T., Reesink H. W., van der Poel C. L., Winkel I., Bakker E., van Exel-Oehlers P. J., Vallari D., Allain J. P., Mimms L. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. J Med Virol. 1992 Jul;37(3):203–209. doi: 10.1002/jmv.1890370310. [DOI] [PubMed] [Google Scholar]
- McHutchison J. G., Person J. L., Govindarajan S., Valinluck B., Gore T., Lee S. R., Nelles M., Polito A., Chien D., DiNello R. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology. 1992 Jan;15(1):19–25. doi: 10.1002/hep.1840150105. [DOI] [PubMed] [Google Scholar]
- Prince A. M., Brotman B., Huima T., Pascual D., Jaffery M., Inchauspé G. Immunity in hepatitis C infection. J Infect Dis. 1992 Mar;165(3):438–443. doi: 10.1093/infdis/165.3.438. [DOI] [PubMed] [Google Scholar]
- Second-generation tests for hepatitis C virus. Ann Intern Med. 1991 Nov 1;115(9):747–748. doi: 10.7326/0003-4819-115-9-747. [DOI] [PubMed] [Google Scholar]
- Teo C. G., Gabriel F. G., Mortimer P. P. Confirmation of second generation anti-hepatitis C virus enzyme immunoassays by antigenic cross-validation. J Clin Pathol. 1992 Oct;45(10):917–920. doi: 10.1136/jcp.45.10.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vallari D. S., Jett B. W., Alter H. J., Mimms L. T., Holzman R., Shih J. W. Serological markers of posttransfusion hepatitis C viral infection. J Clin Microbiol. 1992 Mar;30(3):552–556. doi: 10.1128/jcm.30.3.552-556.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]